Glucagon prescriptions for severe hypoglycemia rose in Medicaid beneficiaries with the introduction of newer products but likely met only a fraction of the high-risk population’s needs.

Hanmi Pharmaceutical develops obesity drugs to increase muscle while reducing fat Hanmi Pharmaceutical pioneers innovative ...

The following is a summary of “Association between incretin-based drugs and risk of cholangiocarcinoma among patients with ...

Israeli and American researchers uncovered the role of a specific enzyme in managing blood sugar levels in a study that opens up new therapeutic possibilities for people with type 2 diabetes. Type 2 ...

Discover why former Real Housewives of Atlanta star Cynthia Bailey quit the weight loss drug Ozempic after giving it a try.

Cancer researchers found that patients on GLP-1s had significant risk reductions for 10 of 13 obesity-associated cancers.

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

Patients with obesity and comorbid cardiovascular disease were more likely to ration prescription drugs than those without obesity.

Retatrutide, an experimental drug by Eli Lilly, shows promising results in weight loss by targeting three hormones, ...

"We see opportunity within our unique snacking portfolio," Tom McGough, co‐chief operating officer with Conagra Brands, told ...

Eli Lilly's experimental weight loss drug, retatrutide, has demonstrated encouraging results in helping obese adults lose weight.

The series A fundraising is the biggest ever for a European biotech firm, according to the data provider PitchBook.